Sight Sciences Files 8-K on Financials
Ticker: SGHT · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1531177
| Field | Detail |
|---|---|
| Company | Sight Sciences, Inc. (SGHT) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, disclosure
TL;DR
Sight Sciences dropped an 8-K on March 7th detailing their financial condition. Check it out.
AI Summary
Sight Sciences, Inc. filed an 8-K on March 7, 2024, to report on its results of operations and financial condition. The filing also includes information related to Regulation FD and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Menlo Park, California.
Why It Matters
This 8-K filing provides an update on Sight Sciences' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Sight Sciences, Inc. (company) — Registrant
- March 07, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Menlo Park, California (location) — Address of Principal Executive Offices
- 877 266-1144 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Sight Sciences, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as disclosures related to Regulation FD and financial statements and exhibits.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported was on March 07, 2024.
In which state is Sight Sciences, Inc. incorporated?
Sight Sciences, Inc. is incorporated in Delaware.
What is the address of Sight Sciences, Inc.'s principal executive offices?
The address is 4040 Campbell Avenue, Suite 100, Menlo Park, California, 94025.
What is the registrant's telephone number as listed in the filing?
The registrant's telephone number is 877 266-1144.
Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-03-07 16:15:23
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share SGHT The Nasdaq
Filing Documents
- sght-20240307.htm (8-K) — 41KB
- sght-ex99_1.htm (EX-99.1) — 321KB
- sght-ex99_2.htm (EX-99.2) — 26KB
- img169022213_0.jpg (GRAPHIC) — 3KB
- sght-ex99_2s1.jpg (GRAPHIC) — 216KB
- sght-ex99_2s2.jpg (GRAPHIC) — 1156KB
- sght-ex99_2s3.jpg (GRAPHIC) — 336KB
- sght-ex99_2s4.jpg (GRAPHIC) — 415KB
- sght-ex99_2s5.jpg (GRAPHIC) — 346KB
- sght-ex99_2s6.jpg (GRAPHIC) — 353KB
- sght-ex99_2s7.jpg (GRAPHIC) — 437KB
- sght-ex99_2s8.jpg (GRAPHIC) — 409KB
- sght-ex99_2s9.jpg (GRAPHIC) — 443KB
- sght-ex99_2s10.jpg (GRAPHIC) — 341KB
- sght-ex99_2s11.jpg (GRAPHIC) — 348KB
- sght-ex99_2s12.jpg (GRAPHIC) — 335KB
- sght-ex99_2s13.jpg (GRAPHIC) — 367KB
- sght-ex99_2s14.jpg (GRAPHIC) — 294KB
- sght-ex99_2s15.jpg (GRAPHIC) — 345KB
- sght-ex99_2s16.jpg (GRAPHIC) — 388KB
- sght-ex99_2s17.jpg (GRAPHIC) — 394KB
- sght-ex99_2s18.jpg (GRAPHIC) — 433KB
- sght-ex99_2s19.jpg (GRAPHIC) — 439KB
- sght-ex99_2s20.jpg (GRAPHIC) — 400KB
- sght-ex99_2s21.jpg (GRAPHIC) — 423KB
- sght-ex99_2s22.jpg (GRAPHIC) — 255KB
- 0000950170-24-027971.txt ( ) — 12758KB
- sght-20240307.xsd (EX-101.SCH) — 26KB
- sght-20240307_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On March 7, 2024, Sight Sciences, Inc. (the "Company") issued a press release announcing its financial results for the year and quarter ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.*
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On March 7, 2024, the Company posted an investor presentation to its website at https://investors.sightsciences.com/. The Company expects to use the investor presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts, and others. A copy of the investor presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.*
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 7, 2024 99.2 Sight Sciences Presentation dated March 7, 2024 104 Cover Page Interactive Data File, formatted in Inline XBRL. * The information in Item 2.02, Item 7.01, Exhibit 99.1, and Exhibit 99.2 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Sight Sciences, Inc. Date: March 7, 2024 By: /s/ Alison Bauerlein Chief Financial Officer